JPRN-UMIN000013430已完成2 期
A phase II study of adjuvant chemotherapy with 5-FU and heparin-based portal infusion chemotherapy followed by TS-1 for patients with resected pancreatic cancer (TOSPAC-02) - A phase II study of portal infusion chemotherapy followed by TS-1 for resected pancreatic cancer (TOSPAC-02)
Tokyo Study Group for Pancreatic Cancer (TOSPAC)0 个研究点目标入组 55 人开始时间: 2014年3月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Pulmonary fibrosis or interstitial pneumonia 2) Uncontrolled pleural effusion 3) Resection of the distant organ metastasis 4) Active double cancer 5) Active infection 6) History of serious complications related to surgery 7) Active peptic ulcer 8) History of myocardial infarction within three months 9) Severe mental disorder 10) Pregnant or breast feeding 11) Patients judged inappropriate for the study by the physicians
研究者
相似试验
已完成
2 期
A phase II study of adjuvant chemotherapy with 5-FU and heparin-based portal infusion chemotherapy followed by gemcitabine for patients with resected pancreatic cancer (TOSPAC-01)Resected pancreatic cancerJPRN-UMIN000004504Tokyo Study Group for Pancreatic Cancer (TOSPAC)50
已完成
2 期
A phase II trial of adjuvant chemotherapy with 5-FU liver perfusion chemotherapy via the portal vein followed by gemcitabine plus S-1 (F-GS therapy) for patients with resectable pancreatic cancer (CCOG-1001)JPRN-UMIN000003768Chubu Clinical Oncology Group45
已完成
2 期
Phase II trial of neoadjuvant chemotherapy with mFOLFOX6 plus Bevacizumab for resectable local recurrent rectal cancerResectable local recurrent rectal cancerJPRN-UMIN000002920agoya Surgical Oncology Group25
招募中
2 期
Phase II study of chemoradiotherapy with 5-FU plus cisplatin followed by S-1 for clinical stage IA esophageal cancerEsophageal cancerJPRN-jRCTs051180094Takehara Tetsuo30
已完成
2 期
Phase II study of chemoradiotherapy with 5-FU plus cisplatin followed by S-1 for clinical stage IA esophageal cancer (definitive chemoradiotherapy)esophageal cancer (clinical stage IA)JPRN-UMIN000015938Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine30